Zydus Cadila wins USFDA Nod for Hydroxychloroquine Sulphate Pills

Zydus Cadila
Chennai: Cadila Healthcare Ltd has received USFDA approval for hydroxychloroquine sulphate tabs in the strength of 200 mg.

The medicine falls under the DMARD (disease modifying anti-rheumatic drug) section, and is used in caring rheumatoid arthritis.

According to NDC Health, the sales of such pills in the US market in 2006 stood at $30 million.

Saudi Arabia to buy Euro-fighter jets worth nine billion dollars

Nicosia, Sept.26: Saudi Arabia has agreed to buy 72 Euro-fighter Typhoon combat jets from Britain worth almost nine billion dollars.

BSE Sensex crossed 17000, Technology Stocks Strong

Indian Stock markets have crossed the 17000 mark. The markets were strong on back of IT Stock and Reliance. This is the fastest gain of 1000 points by BSE Sensex and Bulls have done this is just one week. Technology, market laggards, also participated in the last lap, driving the Sensex to a record high of 17,025.07 early Wednesday.

During the early trades, the markets jumped by nearly 90 points to be close to 17000 target. Infosys, Satyam Computers, Wipro and ICICI bank were among the gainers in Sensex stocks. Markets soon touched their highest 17,025 points.

Modern humans still retain Stone Age survival instincts

Washington, Sept 26 : Modern humans still retain caveman’s survival instincts at spotting predators and prey, despite living in the comforts of modern homes in urban localities, according to a new study published online in this week’s issue of the Proceedings of the National Academy of Sciences (PNAS).

The study reveals that humans today are hard-wired to pay attention to other people and animals much more than non-living things, even if inanimate objects are the primary hazards for modern, urbanized folks.

‘I would allow IAEA to question AQ Khan’: Benazir

Washington, Sep 26 : Former premier Benazir Bhutto has said that if she again becomes Prime Minister of Pakistan, she would allow the International Atomic Energy Agency (IAEA) to question disgraced nuclear scientist Dr AQ Khan.

It has to be determined, if Khan was solely responsible for what he had confessed to, or if there were “others” involved, Bhutto said at the Middle East Institute here.

She went on to say that when in power her party would hold a parliamentary debate over the issue.

11 new plant, animal species discovered in Vietnam’s remote ‘Green Corridor’

Washington, Sept 26 : A WWF expedition has uncovered 11 new plant and animal species in a remote area in central Vietnam.

Scientists said the discovery underscored the importance of conservation efforts in the ancient tropical forests of the region.

The biologists found a snake, five orchids, two butterflies and three other plants new to science and exclusive to the Annamites Mountain Range within the forest region, known as “Green Corridor”.

Pages

News in Focus

L&T Finance Share Price Target at Rs 370: ICICI Securities

ICICI Securities has upgraded L&T Finance (LTF) to a BUY rating from ADD, setting a fresh 12-month target price of Rs 370, implying roughly 15% upside from the current market price of Rs 321.

Suzlon Energy Share Price Target at Rs 65: Deven Choksey Research

Deven Choksey Research has reiterated a BUY rating on Suzlon Energy Ltd ahead of its Q1FY27 results, setting a revised target price of Rs 65 — a 22% upside from the current market price of Rs 53.

Buying Used Cars in Dubai? OneClickDrive, DubiCars, CarSwitch and dubizzle Emerge as Top Platforms

Dubai’s used-car market can be a bargain hunter’s dream and a compliance minefield at the same time.

Anand Rathi Recommends BUY on Indian Bank With Share Price Target at Rs 1,098

Indian Bank has kicked off FY27 on a strong footing, prompting Anand Rathi to reaffirm its BUY recommendation with a 12-month target price of Rs 1,098.

Bajaj Consumer Care Share Price Target at Rs 760: ICICI Securities Issues Bullish Outlook

Bajaj Consumer Care has received a reaffirmed BUY recommendation from ICICI Securities, which has increased its 12-month target price to Rs 760 from Rs 600, implying an upside potential of around 1